leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 23:30:54 - browse：8

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： 1 dead, 9 hurt in July 4th fireworks explosion

leisure time

WSS

Digital health funding stays low as a new reality sets in

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Superbugs, antibiotic resistance get scrutiny in congress

The debate over Covid

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

A timeline of the missing Titanic tourist submersible

hotspot

leisure time

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

After half a century, Israel moves to evict squatter from his cave home on the beach

Alkermes shareholders re

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Alkermes shareholders re

Vermont grapples with historic flooding as more rainstorms head for Northeast

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Churchill Downs extends trainer Bob Baffert's ban through 2024

Wikipedia

Watch the official trailer for 'Ahsoka' series

EU fines Illumina $475 million over Grail acquisition

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Women's World Cup brings attention to abuse in soccer

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Noem? Reynolds? A very early look at the Republican 'veepstakes'

leisure time

explore

leisure time

focus